Latest updates for Evaxion Evx-V1 For Cmv

Fresh curated links around Evaxion EVX-V1 for CMV are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Evaxion Presents New Preclinical Data for AI-Designed CMV Vaccine Program EVX-V1
  • ZEISS Debuts DORC EVA NEXUS For Cataract Surgery At ESCRS
  • Evaxion scraps solid tumor vaccine to focus on Duke-partnered brain cancer candidate

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

hearingreview.com /1 month ago

Evaxion Presents New Preclinical Data for AI-Designed CMV Vaccine Program EVX-V1

New preclinical findings show AI-discovered T-cell epitopes may improve control of CMV infection.

Read source
opticaljournal.com /6 days ago

ZEISS Debuts DORC EVA NEXUS For Cataract Surgery At ESCRS

ZEISS Medical Technology, one of the world’s leading medical technology companies, today announced the availability of the EVA NEXUS™ ophthalmic surgical system from ZEISS in a ded...

Read source
fiercebiotech.com /3 weeks ago

Evaxion scraps solid tumor vaccine to focus on Duke-partnered brain cancer candidate

Evaxion has scrapped a next-gen solid tumor vaccine in order to channel resources to a candidate specifically targeting brain cancer.

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Evaxion Evx-V1 For Cmv

fiercebiotech.com

Recent coverage from public sources
Public source

hearingreview.com

Recent coverage from public sources
Public source

opticaljournal.com

Recent coverage from public sources
Public source